Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma

Surgery

Volumn 128, Issue 6, 2000, Pages 984-993

  Musholt, T J ^a   Musholt, P B ^a   Khaladj, N ^a   Schulz, D ^a   Scheumann, G F W ^a   Klempnauer, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHIMERA; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID PAPILLARY CARCINOMA;

EID: 0033671621     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.110845     Document Type: Article

References (26)

1. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas
2. ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma
3. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype
4. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
5. Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis
6. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A
7. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer
8. Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma
9. Molecular characterization of RET/PTC3; a novel rearranged version of the RET protooncogene in a human thyroid papillary carcinoma
10. Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing
11. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: Biological, phenotypic, and clinical implications
12. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas
13. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas
14. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes
15. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain
16. Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a
17. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain
18. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method
19. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
20. Sporadic ret-rearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms?
21. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes
22. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: Implications for metastatic potential?
23. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma
24. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident
25. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
26. Invasive differentiated thyroid carcinoma: Tracheal resection and reconstruction procedures in the hands of the endocrine surgeon